{"version": "https://jsonfeed.org/version/1.1", "title": "Sharemaestro Newsreel: Hong Kong Drug Manufacturers - General news", "home_page_url": "https://sharemaestro.com/newsreel/hk/healthcare/drug-manufacturers-general/", "feed_url": "https://sharemaestro.com/newsreel/hk/healthcare/drug-manufacturers-general/feed.json", "description": "Latest Drug Manufacturers - General company headlines from Hong Kong, newest first, with source links and direct routes to company research and sentiment.", "language": "en", "items": [{"id": "source:a172fde623cf21980581ad9143e43883b8c1df879dcecf1a336aa0e1c5f36099", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxQR2JXYlM4d1kxZ3RtcXFrNV9KME1BLXBQajdnZ2d0VzdSbzJBNExhOURvUUhGRVhraFAyTHk5VkRidHR0bHpEZ2VUQkd1NzJpekpPSkc1S1BhYWdQa0pfY0J6SUpWckNHaDVtUEJLekg1RTJVNkR5ZFp4cEo3UThMV1JCb28zMXc0X1hJd1B1WDVyaVJOdG1LbmUxSFRuZE5hLXEzQ0xMVnV3S2xyS19NQ0FHc2p6NnU0a2tjcXpQb1RDWlNBbXZhVTY5XzVOdUV1OEJKdXFjODJQYTdY?oc=5", "external_url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxQR2JXYlM4d1kxZ3RtcXFrNV9KME1BLXBQajdnZ2d0VzdSbzJBNExhOURvUUhGRVhraFAyTHk5VkRidHR0bHpEZ2VUQkd1NzJpekpPSkc1S1BhYWdQa0pfY0J6SUpWckNHaDVtUEJLekg1RTJVNkR5ZFp4cEo3UThMV1JCb28zMXc0X1hJd1B1WDVyaVJOdG1LbmUxSFRuZE5hLXEzQ0xMVnV3S2xyS19NQ0FHc2p6NnU0a2tjcXpQb1RDWlNBbXZhVTY5XzVOdUV1OEJKdXFjODJQYTdY?oc=5", "title": "Alebund Pharmaceuticals Wins Shareholder Backing for Auditor Change and New Capital Mandates", "content_text": "Alebund Pharmaceuticals Wins Shareholder Backing for Auditor Change and New Capital Mandates", "date_published": "2026-08-14T10:54:21+00:00", "authors": [{"name": "TipRanks"}], "tags": ["Market update", "9637"], "_sharemaestro": {"country": "Hong Kong", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "9637", "name": "Alebund Pharmaceuticals (Jiangsu) Limited", "sentiment_url": "https://sharemaestro.com/sentiment/32b085ce-3117-4d93-8045-9c00e1cf1bf7/"}]}}, {"id": "source:3fe838b3911d71ded0eb2f1ea7a3c82431d07006f5f743ac1d3efe5d246f37b1", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxOU1ZaOF80WFdKdmFTbU83UGNOWWNxSHRVdEQ3OGkyUXdFM2g1MnRDai1jNlhaZ2QwamtoT2RhREJIYkc4cUdGRnFVUW1meTktanJqZ3NIQlJMQUpMRzRtNkRzOXRpTzJaYTZjblZjSnRFVUcxYXdpNWdmcERTWGpnMklod25IOWwwbUZkVDBUUkMxUXNFTkZRQ2J0UkxmUXdMWFZ1dVJhek5WdWpQSE1haGxibmVodTg1UTRlai11VUw0NnYxbjNuY0tUUmJ4a3JGSTdDT05LdEx4Wk0?oc=5", "external_url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxOU1ZaOF80WFdKdmFTbU83UGNOWWNxSHRVdEQ3OGkyUXdFM2g1MnRDai1jNlhaZ2QwamtoT2RhREJIYkc4cUdGRnFVUW1meTktanJqZ3NIQlJMQUpMRzRtNkRzOXRpTzJaYTZjblZjSnRFVUcxYXdpNWdmcERTWGpnMklod25IOWwwbUZkVDBUUkMxUXNFTkZRQ2J0UkxmUXdMWFZ1dVJhek5WdWpQSE1haGxibmVodTg1UTRlai11VUw0NnYxbjNuY0tUUmJ4a3JGSTdDT05LdEx4Wk0?oc=5", "title": "Alebund Pharmaceuticals Signals Surging Revenue and Narrowing Losses for First Half of 2026", "content_text": "Alebund Pharmaceuticals Signals Surging Revenue and Narrowing Losses for First Half of 2026", "date_published": "2026-08-13T18:56:23+00:00", "authors": [{"name": "TipRanks"}], "tags": ["Earnings", "9637"], "_sharemaestro": {"country": "Hong Kong", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "9637", "name": "Alebund Pharmaceuticals (Jiangsu) Limited", "sentiment_url": "https://sharemaestro.com/sentiment/32b085ce-3117-4d93-8045-9c00e1cf1bf7/"}]}}, {"id": "source:e47c57004f23f07515703735f86654cfec6bd72c0d59da3b65e1156f58f706e5", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNeHc0RWk3SVRLNi1COVRfVDYtN1lFd0NrdEJKTkJNdXdXUVBWM1Y5Z1hnRXVxZ0kyV3NiWHBFTGNBcTlXaGEwdUFSOWtWZzFWY3BJWFJ3QWl6Ri1UTU9CQm4xRkJBNjFoMmFOZGZPck92V3dxMk1qX1ZXbTI5X05Ia25IMWpnSThlbk1GZkl6QktKVVZxZjNSTDB4TFdWekVYZG01T2x1M1NLSWpfblNwVFlpUnpkWnVvNDNYalNhcF9idmVX?oc=5", "external_url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNeHc0RWk3SVRLNi1COVRfVDYtN1lFd0NrdEJKTkJNdXdXUVBWM1Y5Z1hnRXVxZ0kyV3NiWHBFTGNBcTlXaGEwdUFSOWtWZzFWY3BJWFJ3QWl6Ri1UTU9CQm4xRkJBNjFoMmFOZGZPck92V3dxMk1qX1ZXbTI5X05Ia25IMWpnSThlbk1GZkl6QktKVVZxZjNSTDB4TFdWekVYZG01T2x1M1NLSWpfblNwVFlpUnpkWnVvNDNYalNhcF9idmVX?oc=5", "title": "Alebund Pharmaceuticals Sets Board Meeting to Approve 2026 Interim Results", "content_text": "Alebund Pharmaceuticals Sets Board Meeting to Approve 2026 Interim Results", "date_published": "2026-08-13T12:19:15+00:00", "authors": [{"name": "TipRanks"}], "tags": ["Earnings", "9637"], "_sharemaestro": {"country": "Hong Kong", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "9637", "name": "Alebund Pharmaceuticals (Jiangsu) Limited", "sentiment_url": "https://sharemaestro.com/sentiment/32b085ce-3117-4d93-8045-9c00e1cf1bf7/"}]}}, {"id": "source:b06d97d5bf70ab1fce241286405bc7f74fa28e2dc8eb0f278190f84be94b01e1", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxNRkF1VGh3WTVZanZxMjFaQzd2UEFmbkxzWjZVckVlTG05VDNmUlgzVTc2ak5nTGFOeWd3YUFYR2ZpN1d4WmVGRW9NTngxa3h6a0JXSlQ1ZDJNWENQMHBhR0owYVp4ZlppNTNrMWp2cHV3ZEVqWDlRY1NLNk1paEpuckdmamFxUkJkdVZHZnFxQ0pGNWw2V1lNUWFwZ3FleFVxODJmR3VHQ3pSV2dacDZCcUZOYUpSUF9PT09MVkFuNHNMUWM?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxNRkF1VGh3WTVZanZxMjFaQzd2UEFmbkxzWjZVckVlTG05VDNmUlgzVTc2ak5nTGFOeWd3YUFYR2ZpN1d4WmVGRW9NTngxa3h6a0JXSlQ1ZDJNWENQMHBhR0owYVp4ZlppNTNrMWp2cHV3ZEVqWDlRY1NLNk1paEpuckdmamFxUkJkdVZHZnFxQ0pGNWw2V1lNUWFwZ3FleFVxODJmR3VHQ3pSV2dacDZCcUZOYUpSUF9PT09MVkFuNHNMUWM?oc=5", "title": "Alebund\u2019s AP301 NDA Accepted in China After Strong Phase III Dialysis Data", "content_text": "Alebund\u2019s AP301 NDA Accepted in China After Strong Phase III Dialysis Data", "date_published": "2026-08-07T11:40:43+00:00", "authors": [{"name": "TipRanks"}], "tags": ["Market update", "9637"], "_sharemaestro": {"country": "Hong Kong", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "9637", "name": "Alebund Pharmaceuticals (Jiangsu) Limited", "sentiment_url": "https://sharemaestro.com/sentiment/32b085ce-3117-4d93-8045-9c00e1cf1bf7/"}]}}, {"id": "source:724facb05ce8c1ee7a71fc14a761e9c91af95d0e62579426af18dc4a9b114508", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxQcGxleTJvaXJWM2d0M3lIR2doMVhnOS16RVVKU3hjb3N2eWw4eDdaVXl1b2NYU0VRMkZva2NuUlRaUENUZ0g1WVVsel9DcVE2S0NqYm40RkJGdnllenZOR1BhclZaVzYwWG1zWjBKNGJ2OExKemgzU0x4UkFEYUpFdWVEWnNGZmtkUmZVMTE2cHdkcG8?oc=5", "external_url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxQcGxleTJvaXJWM2d0M3lIR2doMVhnOS16RVVKU3hjb3N2eWw4eDdaVXl1b2NYU0VRMkZva2NuUlRaUENUZ0g1WVVsel9DcVE2S0NqYm40RkJGdnllenZOR1BhclZaVzYwWG1zWjBKNGJ2OExKemgzU0x4UkFEYUpFdWVEWnNGZmtkUmZVMTE2cHdkcG8?oc=5", "title": "ALEBUND PHARMACEUTICALS (JIANGSU) LIMITED", "content_text": "ALEBUND PHARMACEUTICALS (JIANGSU) LIMITED", "date_published": "2026-08-07T03:12:48+00:00", "authors": [{"name": "marketscreener.com"}], "tags": ["Market update", "9637"], "_sharemaestro": {"country": "Hong Kong", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "9637", "name": "Alebund Pharmaceuticals (Jiangsu) Limited", "sentiment_url": "https://sharemaestro.com/sentiment/32b085ce-3117-4d93-8045-9c00e1cf1bf7/"}]}}, {"id": "source:f6cd006764df496b7b82c9ddddac73c41a96f7feee6b4535020bb890185271cd", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOQTZnODhLYUZpRlpHTkh1TzVyVFFMcFhUNFFCWkdvVzFpT3dUS0dJd2hwZVU5R3JDNF9uVldwajlrMkZzbGdUQTZwNHZkTXU3eUpQV0lkTlVVbFlSdExMX1pKZFhqRTlnMW1WdHl1bmxiMXZINkhDYVhjN0ZUbll3NEVRMjRsMVItMEpxV1JxTC1aZ1ZEM2h4a2huamFGMDBINEV4TkM3TmlGZC1Wb2liUjR3TEZEVmdhMV9kTnF3?oc=5", "external_url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOQTZnODhLYUZpRlpHTkh1TzVyVFFMcFhUNFFCWkdvVzFpT3dUS0dJd2hwZVU5R3JDNF9uVldwajlrMkZzbGdUQTZwNHZkTXU3eUpQV0lkTlVVbFlSdExMX1pKZFhqRTlnMW1WdHl1bmxiMXZINkhDYVhjN0ZUbll3NEVRMjRsMVItMEpxV1JxTC1aZ1ZEM2h4a2huamFGMDBINEV4TkM3TmlGZC1Wb2liUjR3TEZEVmdhMV9kTnF3?oc=5", "title": "Alebund Pharmaceuticals Updates Articles After H-Share Over-Allotment", "content_text": "Alebund Pharmaceuticals Updates Articles After H-Share Over-Allotment", "date_published": "2026-07-29T13:25:13+00:00", "authors": [{"name": "TipRanks"}], "tags": ["Market update", "9637"], "_sharemaestro": {"country": "Hong Kong", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "9637", "name": "Alebund Pharmaceuticals (Jiangsu) Limited", "sentiment_url": "https://sharemaestro.com/sentiment/32b085ce-3117-4d93-8045-9c00e1cf1bf7/"}]}}, {"id": "source:5b30c5795a8343d7dd7b39bf6dea71b6f1e7370508edd5a04da03df11b0d2279", "url": "https://news.google.com/rss/articles/CBMijAJBVV95cUxNRTczTEdnZlhyZndjY2R3VlNLamJyZ3pKaDdmcW1wTVhJbVpUV2w3YW9QeDBWa2QydjNKcnlKbWdYNGJ0UGRxckZ6aWRsQ2JxUGkzR0FmelBTREVKT1lXUlYwOVhORkpHZmdZd29uQnJMQ2pTdHYyeW5JR1VILUl1Nm0zbEgzVDlkdTFtd05meFpjLWlZTmNRdjkxaWRsQ2pCNDBSYUFFdUoxQm9HVjE4Y3BKeUtfUGszUnNQaUl5SXdMMWNyNHhmNWN5UkN2QzVVOFdUeVNEYmFsM3hZNU1HendmQ3BkOEZXMmgxNllQV01jdUN3ZEc4eTlMYmFsNTZzNlpYWGxQNk1tNzRL?oc=5", "external_url": "https://news.google.com/rss/articles/CBMijAJBVV95cUxNRTczTEdnZlhyZndjY2R3VlNLamJyZ3pKaDdmcW1wTVhJbVpUV2w3YW9QeDBWa2QydjNKcnlKbWdYNGJ0UGRxckZ6aWRsQ2JxUGkzR0FmelBTREVKT1lXUlYwOVhORkpHZmdZd29uQnJMQ2pTdHYyeW5JR1VILUl1Nm0zbEgzVDlkdTFtd05meFpjLWlZTmNRdjkxaWRsQ2pCNDBSYUFFdUoxQm9HVjE4Y3BKeUtfUGszUnNQaUl5SXdMMWNyNHhmNWN5UkN2QzVVOFdUeVNEYmFsM3hZNU1HendmQ3BkOEZXMmgxNllQV01jdUN3ZEc4eTlMYmFsNTZzNlpYWGxQNk1tNzRL?oc=5", "title": "Jiangxi Bio's Veterinary Tetanus Antitoxin Production Line Officially Commenced Production,Accelerating Commercialization of the Animal Antiserum Portfolio", "content_text": "Jiangxi Bio's Veterinary Tetanus Antitoxin Production Line Officially Commenced Production,Accelerating Commercialization of the Animal Antiserum Portfolio", "date_published": "2026-07-27T23:20:53+00:00", "authors": [{"name": "Macau Business"}], "tags": ["Market update", "6915"], "_sharemaestro": {"country": "Hong Kong", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "6915", "name": "JIANGXI BIO", "sentiment_url": "https://sharemaestro.com/sentiment/f1a4e7df-7df1-4d96-9d68-88684006e2b0/"}]}}, {"id": "source:817f9ffe955837f9523a156a74d797d5d505c636270d695e3046e2a1e00ea912", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxQQ1I1QXU2RDdfaFdleWpBSHl6cm93LUxXcnZiVHNlTjRHLUlhU0hZYzg3U2FuVlZqbktRaER1M1JIVWo5akotNU9pcWZiYWFTbVdIYlhfbk1Kd3RuWkJ6Ry1mU0NOS0JuR2RxMWttRGZ5aVNYMkhYaWN4M0FKc1NKWXkzanFYNlVVRTd2UElSRk1CeHAzenRhOF9yc0dzSk43TFBOMFltQXpkMVlsamFJ?oc=5", "external_url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxQQ1I1QXU2RDdfaFdleWpBSHl6cm93LUxXcnZiVHNlTjRHLUlhU0hZYzg3U2FuVlZqbktRaER1M1JIVWo5akotNU9pcWZiYWFTbVdIYlhfbk1Kd3RuWkJ6Ry1mU0NOS0JuR2RxMWttRGZ5aVNYMkhYaWN4M0FKc1NKWXkzanFYNlVVRTd2UElSRk1CeHAzenRhOF9yc0dzSk43TFBOMFltQXpkMVlsamFJ?oc=5", "title": "Jiangxi Biological (6915.HK) has officially commenced production at its veterinary TAT manufacturing line, with commercialization providing further catalyst for stock price recovery.", "content_text": "Jiangxi Biological (6915.HK) has officially commenced production at its veterinary TAT manufacturing line, with commercialization providing further catalyst for stock price recovery.", "date_published": "2026-07-27T02:16:27+00:00", "authors": [{"name": "news.futunn.com"}], "tags": ["Market update", "6915"], "_sharemaestro": {"country": "Hong Kong", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "6915", "name": "JIANGXI BIO", "sentiment_url": "https://sharemaestro.com/sentiment/f1a4e7df-7df1-4d96-9d68-88684006e2b0/"}]}}]}